Co-Diagnostics (CODX) vs Vivos Therapeutics (VVOS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Vivos Therapeutics is the larger company by market cap ($1.8 million vs $1.4 million), about 1.3 times the size. Vivos Therapeutics converts more of its revenue into profit, with a net margin of -121.4% versus -7533.6%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CODX | VVOS |
|---|---|---|
| Share price | $0.1295 | $0.054 |
| Market cap | $1.36M | $1.83M |
| 1-day change | -21.32% | -5.10% |
| EPS (TTM) | $-21.71 | $-1.35 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $622.49K | $17.44M |
| Revenue growth (YoY) | -84.10% | +16.05% |
| Net income (latest FY) | $-46.90M | $-21.17M |
| Gross margin | 64.28% | 60.44% |
| Operating margin | -8058.83% | -114.05% |
| Net margin | -7533.62% | -121.37% |
| 52-week high | $13.54 | $2.69 |
| 52-week low | $0.1276 | $0.05 |
| Distance from 52-week high | -99.04% | -97.99% |
| Analyst consensus | none | none |
| Avg. price target upside | +2988.80% | +3825.93% |
| Average volume | 2.03M | 14.44M |
| Shares outstanding | 10.51M | 33.82M |
| Employees | 115 | 268 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Vivos Therapeutics is more profitable, keeping -121.4 cents of every revenue dollar as net income versus -7533.6 cents for Co-Diagnostics.
- Vivos Therapeutics grew revenue faster in its latest fiscal year (+16.05% vs -84.10%).
About Co-Diagnostics
CODX stock →Co-Diagnostics, Inc. operates as a molecular diagnostics company that develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally.
Health Care · Medical/Dental Instruments · 115 employees
About Vivos Therapeutics
VVOS stock →Vivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
Health Care · Medical/Dental Instruments · 268 employees
CODX vs VVOS FAQ
Which is bigger, Co-Diagnostics or Vivos Therapeutics?
Vivos Therapeutics (VVOS) is larger, with a market capitalization of $1.83M compared with $1.36M for Co-Diagnostics (CODX).
Are Co-Diagnostics and Vivos Therapeutics in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.